NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 182 filers reported holding NEVRO CORP in Q2 2022. The put-call ratio across all filers is 1.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $337,388 | -96.7% | 17,554 | -95.6% | 0.00% | -100.0% |
Q2 2023 | $10,177,880 | -26.8% | 400,389 | +4.1% | 0.01% | -28.6% |
Q1 2023 | $13,906,822 | -8.9% | 384,698 | -0.2% | 0.01% | -12.5% |
Q4 2022 | $15,260,295 | +2.4% | 385,361 | +20.5% | 0.01% | 0.0% |
Q3 2022 | $14,904,000 | -65.2% | 319,822 | -67.2% | 0.01% | -61.9% |
Q2 2022 | $42,797,000 | -39.8% | 976,418 | -0.7% | 0.02% | -25.0% |
Q1 2022 | $71,113,000 | -3.7% | 983,160 | +7.9% | 0.03% | +3.7% |
Q4 2021 | $73,883,000 | -30.5% | 911,357 | -0.3% | 0.03% | -32.5% |
Q3 2021 | $106,362,000 | -34.1% | 913,916 | -6.1% | 0.04% | -35.5% |
Q2 2021 | $161,353,000 | +13.6% | 973,240 | -4.4% | 0.06% | +6.9% |
Q1 2021 | $142,059,000 | -20.9% | 1,018,344 | -1.8% | 0.06% | -23.7% |
Q4 2020 | $179,489,000 | +22.5% | 1,036,908 | -1.5% | 0.08% | +7.0% |
Q3 2020 | $146,581,000 | +0.7% | 1,052,266 | -3.2% | 0.07% | -5.3% |
Q2 2020 | $145,608,000 | +17.8% | 1,087,604 | -12.0% | 0.08% | -8.5% |
Q1 2020 | $123,559,000 | -21.1% | 1,236,057 | -7.2% | 0.08% | 0.0% |
Q4 2019 | $156,629,000 | +20.9% | 1,332,644 | -11.6% | 0.08% | +17.1% |
Q3 2019 | $129,516,000 | -4.0% | 1,506,772 | -27.6% | 0.07% | -2.8% |
Q2 2019 | $134,856,000 | +1.6% | 2,080,119 | -2.0% | 0.07% | +1.4% |
Q1 2019 | $132,717,000 | +67.6% | 2,123,291 | +4.2% | 0.07% | +47.9% |
Q4 2018 | $79,204,000 | -39.9% | 2,036,916 | -11.9% | 0.05% | -27.3% |
Q3 2018 | $131,763,000 | -5.6% | 2,311,505 | +32.2% | 0.07% | -8.3% |
Q2 2018 | $139,600,000 | +2.8% | 1,748,572 | +11.6% | 0.07% | +4.3% |
Q1 2018 | $135,794,000 | +23.5% | 1,566,775 | -1.6% | 0.07% | +30.2% |
Q4 2017 | $109,957,000 | -22.1% | 1,592,451 | +2.5% | 0.05% | -23.2% |
Q3 2017 | $141,141,000 | +23.0% | 1,553,227 | +0.7% | 0.07% | +21.1% |
Q2 2017 | $114,748,000 | -13.6% | 1,541,934 | +8.8% | 0.06% | -14.9% |
Q1 2017 | $132,746,000 | +7.3% | 1,416,799 | -16.8% | 0.07% | +4.7% |
Q4 2016 | $123,696,000 | -28.0% | 1,702,389 | +3.4% | 0.06% | -28.9% |
Q3 2016 | $171,890,000 | +59.1% | 1,646,757 | +12.4% | 0.09% | +55.2% |
Q2 2016 | $108,045,000 | +31.8% | 1,464,818 | +0.5% | 0.06% | +31.8% |
Q1 2016 | $81,970,000 | -11.1% | 1,457,000 | +6.7% | 0.04% | -6.4% |
Q4 2015 | $92,194,000 | +59.4% | 1,365,626 | +9.5% | 0.05% | +62.1% |
Q3 2015 | $57,829,000 | +46.3% | 1,246,590 | +69.5% | 0.03% | +61.1% |
Q2 2015 | $39,521,000 | +34.9% | 735,261 | +20.3% | 0.02% | +38.5% |
Q1 2015 | $29,295,000 | +30.5% | 611,199 | +5.3% | 0.01% | +30.0% |
Q4 2014 | $22,453,000 | – | 580,623 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |